Borriello, L.; Jarray, R.; Rignault-Bricard, R.; Montes, M.; Lopez, N.; Maciel, T.T.; Hermine, O.; Raynaud, F.; Demange, L.; Lepelletier, Y.
Neuropilin Antagonists (NRPas) Block the Phosphorylation of the Cancer Therapeutic Key Factor p38α Kinase Triggering Cell Death. Molecules 2025, 30, 1494.
https://doi.org/10.3390/molecules30071494
AMA Style
Borriello L, Jarray R, Rignault-Bricard R, Montes M, Lopez N, Maciel TT, Hermine O, Raynaud F, Demange L, Lepelletier Y.
Neuropilin Antagonists (NRPas) Block the Phosphorylation of the Cancer Therapeutic Key Factor p38α Kinase Triggering Cell Death. Molecules. 2025; 30(7):1494.
https://doi.org/10.3390/molecules30071494
Chicago/Turabian Style
Borriello, Lucia, Rafika Jarray, Rachel Rignault-Bricard, Matthieu Montes, Nicolas Lopez, Thiago Trovati Maciel, Olivier Hermine, Françoise Raynaud, Luc Demange, and Yves Lepelletier.
2025. "Neuropilin Antagonists (NRPas) Block the Phosphorylation of the Cancer Therapeutic Key Factor p38α Kinase Triggering Cell Death" Molecules 30, no. 7: 1494.
https://doi.org/10.3390/molecules30071494
APA Style
Borriello, L., Jarray, R., Rignault-Bricard, R., Montes, M., Lopez, N., Maciel, T. T., Hermine, O., Raynaud, F., Demange, L., & Lepelletier, Y.
(2025). Neuropilin Antagonists (NRPas) Block the Phosphorylation of the Cancer Therapeutic Key Factor p38α Kinase Triggering Cell Death. Molecules, 30(7), 1494.
https://doi.org/10.3390/molecules30071494